Sun Pharmaceutical Industries Limited

This Phase 3 trial is testing whether regular injections of the drug tildrakizumab can safely clear skin and reduce itching in adults with moderate to severe genital psoriasis. The study will compare the drug against a placebo in about 206 participants. The main goal is to see if…

This Phase 3 study is testing whether the drug tildrakizumab helps control active psoriatic arthritis in people who haven't tried certain other arthritis medications. About 296 participants will receive either the actual drug or a placebo injection to compare effectiveness and sa…

This study is testing a medication called tildrakizumab to see if it can effectively and safely control moderate-to-severe plaque psoriasis in children and teenagers aged 6 to 18. It will compare the drug against a placebo (an inactive substance) and another approved treatment. T…

This study continues monitoring patients who previously participated in tildrakizumab trials for psoriatic arthritis. Researchers are tracking 529 participants to understand the drug's long-term safety and how well it continues to control joint pain and swelling over time. The st…

This study aims to understand how a prescription acne cream (clascoterone 1%) works by looking at changes in facial oil glands. Researchers will take small skin samples and analyze facial oil from 10 adults with moderate acne before and after 3 months of treatment. The goal is to…